DEFECTIVE INTERLEUKIN-2R GENE-EXPRESSION IN GASTRIC-CARCINOMA PATIENTS

被引:2
|
作者
SURESH, K
JAYAVARDHANAN, KK
VASUDEVAN, DM
机构
[1] Department of Biochemistry Medical College, Trichur, Kerala
关键词
D O I
10.3109/08820139509066857
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peripheral blood T lymphocytes from 15 patients with gastric carcinoma and 6 normal healthy controls were evaluated for Interleukin-2 R gene expression. Total RNA was extracted from T cell-enriched fractions of patients as well as from control peripheral blood lymphocytes, with or without mitogenic stimulation. The presence of mRNA for IL-2 R alpha evaluated by Northern blot analysis revealed that unstimulated T cells expressed lower levels of IL-2 R mRNA than PHA stimulated T cells. Expression of both IL-2 R alpha transcripts (3.5 and 1.5 Kb) were either not detectable or only weakly detectable on T lymphocytes from patients even after mitogenic stimulation. In contrast, a significant rise in the expression of both IL-2 R alpha transcripts was observed on T cells from normal controls followed by mitogenic challenge. This paper reports on the defective IL-2 R alpha gene expression in gastric carcinoma patients, which may explain one of the causes of immunodeficiency associated with neoplastic transformation and progression.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 50 条
  • [11] EFFECTS OF HEMODIALYSIS ON INTERLEUKIN-2 GENE-EXPRESSION
    XING, CY
    WANG, XY
    KIDNEY INTERNATIONAL, 1995, 48 (02) : 648 - 649
  • [12] RANDOMIZED COMPARISON OF R1 AND R2-GASTRECTOMY FOR GASTRIC-CARCINOMA
    DENT, DM
    MADDEN, MV
    PRICE, SK
    BRITISH JOURNAL OF SURGERY, 1988, 75 (02) : 110 - 112
  • [13] IMPROVED PROGNOSIS FOR GASTRIC-CARCINOMA WITH R1 AND R2 LYMPHADENECTOMY
    JATZKO, G
    CHIRURG, 1995, 66 (02): : 163 - 163
  • [14] REGULATION OF INTERLEUKIN-2 GENE-EXPRESSION - DISCREPANCY BETWEEN ENHANCER ACTIVITY AND ENDOGENOUS GENE-EXPRESSION
    MARTENSSON, IL
    LEANDERSON, T
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (01) : 145 - 149
  • [15] HER-2/NEU ONCOGENE EXPRESSION AND PROGNOSIS IN GASTRIC-CARCINOMA
    LEE, EY
    CIBULL, ML
    STRODEL, WE
    HALEY, J
    LABORATORY INVESTIGATION, 1992, 66 (01) : A44 - A44
  • [16] Analysis of the gene-expression profile regarding the progression of human gastric carcinoma
    Mori, M
    Mimori, K
    Yoshikawa, Y
    Shibuta, K
    Utsunomiya, T
    Sadanaga, N
    Tanaka, F
    Matsuyama, A
    Inoue, H
    Sugimachi, K
    SURGERY, 2002, 131 (01) : S39 - S47
  • [17] THE RELATIONSHIP OF P53 EXPRESSION TO THE PROGNOSIS OF 418 PATIENTS WITH GASTRIC-CARCINOMA
    GABBERT, HE
    MULLER, W
    SCHNEIDERS, A
    MEIER, S
    HOMMEL, G
    CANCER, 1995, 76 (05) : 720 - 726
  • [18] CURATIVE GASTRECTOMY FROM GASTRIC-CARCINOMA - R1 VERSUS R2
    WELCH, NT
    FIELDING, JWL
    GUT, 1994, 35 (11) : A1681 - A1681
  • [19] REHABILITATION TREATMENT OF PATIENTS WITH OPERABLE GASTRIC-CARCINOMA
    KULIKOV, EP
    LEBEDEV, AM
    TELEGIN, VN
    MAKSIMOVA, TN
    KHIRURGIYA, 1991, (04): : 28 - 33
  • [20] CAMPYLOBACTER-PYLORIDIS IN PATIENTS WITH GASTRIC-CARCINOMA
    CHENG, SCW
    SANDERSON, CR
    WATERS, TE
    GOODWIN, CS
    MEDICAL JOURNAL OF AUSTRALIA, 1987, 147 (04) : 202 - 203